» Articles » PMID: 30794026

Diazepam Inhibits Post-Traumatic Neurogenesis and Blocks Aberrant Dendritic Development

Overview
Journal J Neurotrauma
Publisher Mary Ann Liebert
Date 2019 Feb 23
PMID 30794026
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) triggers a robust increase in neurogenesis within the dentate gyrus of the hippocampus, but these new neurons undergo aberrant maturation and dendritic outgrowth. Because gamma-aminobutyric acid (GABA) receptors (GABARs) modulate dendritic outgrowth during constitutive neurogenesis and GABAR-modulating sedatives are often administered to human patients after TBI, we investigated whether the benzodiazepine, diazepam (DZP), alters post-injury hippocampal neurogenesis. We used a controlled cortical impact (CCI) model of TBI in adult mice, and administered DZP or vehicle continuously for 1 week after injury via osmotic pump. Although DZP did not affect the neurogenesis rate in control mice, it almost completely prevented the TBI-induced increase in hippocampal neurogenesis as well as the aberrant dendritic growth of neurons born after TBI. DZP did not reduce cortical injury, reactive gliosis, or cell proliferation early after injury, but decreased c-Fos activation in the dentate gyrus at both early and late time-points after TBI, suggesting an association between neuronal activity and post-injury neurogenesis. Because DZP blocks post-injury neurogenesis, further studies are warranted to assess whether benzodiazepines alter cognitive recovery or the development of complications after TBI.

Citing Articles

Anesthesia and analgesia for experimental craniotomy in mice and rats: a systematic scoping review comparing the years 2009 and 2019.

King H, Reiber M, Philippi V, Stirling H, Aulehner K, Bankstahl M Front Neurosci. 2023; 17:1143109.

PMID: 37207181 PMC: 10188949. DOI: 10.3389/fnins.2023.1143109.


Are GABAergic drugs beneficial in providing neuroprotection after traumatic brain injuries? A comprehensive literature review of preclinical studies.

Sudhakar S Front Neurol. 2023; 14:1109406.

PMID: 36816561 PMC: 9931759. DOI: 10.3389/fneur.2023.1109406.


Lipocalin-2 Is a Key Regulator of Neuroinflammation in Secondary Traumatic and Ischemic Brain Injury.

Kim J, Kang R, Hyeon S, Ryu H, Joo H, Bu Y Neurotherapeutics. 2022; 20(3):803-821.

PMID: 36508119 PMC: 10275845. DOI: 10.1007/s13311-022-01333-5.


Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury.

Hu Y, Tao W Front Mol Neurosci. 2021; 14:750810.

PMID: 34899180 PMC: 8662751. DOI: 10.3389/fnmol.2021.750810.


Blockade of TRPC Channels Limits Cholinergic-Driven Hyperexcitability and Seizure Susceptibility After Traumatic Brain Injury.

Carver C, DeWitt H, Stoja A, Shapiro M Front Neurosci. 2021; 15:681144.

PMID: 34489621 PMC: 8416999. DOI: 10.3389/fnins.2021.681144.


References
1.
Hsieh J, Eisch A . Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind. Neurobiol Dis. 2010; 39(1):73-84. PMC: 2874108. DOI: 10.1016/j.nbd.2010.01.008. View

2.
Carlson S, Madathil S, Sama D, Gao X, Chen J, Saatman K . Conditional overexpression of insulin-like growth factor-1 enhances hippocampal neurogenesis and restores immature neuron dendritic processes after traumatic brain injury. J Neuropathol Exp Neurol. 2014; 73(8):734-46. PMC: 4102886. DOI: 10.1097/NEN.0000000000000092. View

3.
Eriksson P, Perfilieva E, Bjork-Eriksson T, Alborn A, Nordborg C, Peterson D . Neurogenesis in the adult human hippocampus. Nat Med. 1998; 4(11):1313-7. DOI: 10.1038/3305. View

4.
Xie C, Cong D, Wang X, Wang Y, Liang H, Zhang X . The effect of simvastatin treatment on proliferation and differentiation of neural stem cells after traumatic brain injury. Brain Res. 2014; 1602:1-8. DOI: 10.1016/j.brainres.2014.03.021. View

5.
Bourin M, Hascoet M, Mansouri B, Colombel M, Bradwejn J . Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J Psychiatry Neurosci. 1992; 17(2):72-7. PMC: 1188404. View